AGP Picks
View all

Middle East News Journal
Provided by AGP

Middle East News Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Journal.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 27, 2026

Micron Biomedical Expands Leadership to Mobilize for Pivotal Studies and Commercialization of First Needle-Free Dissolvable Vaccines and Therapeutics
May 27, 2026

Micron Biomedical Expands Leadership to Mobilize for Pivotal Studies and Commercialization of First Needle-Free Dissolvable Vaccines and Therapeutics

Indeterminate GlobeNewswire
Tabnine Named a Visionary in the 2026 Gartner® Magic Quadrant™ for Enterprise AI Coding Agents
May 27, 2026

Tabnine Named a Visionary in the 2026 Gartner® Magic Quadrant™ for Enterprise AI Coding Agents

Indeterminate GlobeNewswire
Enlivex Treasury Portfolio Update: Rain Protocol Jumps Into Top Three Global Prediction Markets In League Table Following $100M In Additional Liquidity
May 27, 2026

Enlivex Treasury Portfolio Update: Rain Protocol Jumps Into Top Three Global Prediction Markets In League Table Following $100M In Additional Liquidity

Indeterminate GlobeNewswire
New IMPACT Phase 2b Data Highlight Concurrent Improvements Across Multiple Non-Invasive Markers and qFibrosis-Measured Fibrosis Regression with Pemvidutide in MASH at EASL 2026
May 27, 2026

New IMPACT Phase 2b Data Highlight Concurrent Improvements Across Multiple Non-Invasive Markers and qFibrosis-Measured Fibrosis Regression with Pemvidutide in MASH at EASL 2026

Indeterminate GlobeNewswire
NewCelX Ltd. Submits Pre-IND Package to the FDA for NCEL-101 for the Treatment of Type 1 Diabetes
May 27, 2026

NewCelX Ltd. Submits Pre-IND Package to the FDA for NCEL-101 for the Treatment of Type 1 Diabetes

Indeterminate GlobeNewswire
Allot to Meet Investors at the 46th Annual William Blair Growth Stock Conference on June 2, 2026
May 27, 2026

Allot to Meet Investors at the 46th Annual William Blair Growth Stock Conference on June 2, 2026

Indeterminate GlobeNewswire
Transforming Rural Health Care Through a First-of-its-Kind Collaborative
May 27, 2026

Transforming Rural Health Care Through a First-of-its-Kind Collaborative

Indeterminate GlobeNewswire
BridgeBio Announces FDA Acceptance and Priority Review of NDA for BBP-418 for LGMD2I/R9
May 27, 2026

BridgeBio Announces FDA Acceptance and Priority Review of NDA for BBP-418 for LGMD2I/R9

Indeterminate GlobeNewswire
Context Therapeutics to Present at the Jefferies Global Healthcare Conference
May 27, 2026

Context Therapeutics to Present at the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire
Morocco Strategic Minerals Corp. Enters Agreement to Sell Sakami Property in Québec
May 27, 2026

Morocco Strategic Minerals Corp. Enters Agreement to Sell Sakami Property in Québec

Indeterminate GlobeNewswire
Corporation de Minéraux Stratégiques du Maroc conclut une entente pour la vente de la propriété Sakami au Québec
May 27, 2026

Corporation de Minéraux Stratégiques du Maroc conclut une entente pour la vente de la propriété Sakami au Québec

Indeterminate GlobeNewswire
Goliath Resources Mobilizes For A Fully Funded 50,000 Meter Expansion Drill Program On Surebet Discovery, Golden Triangle, B.C.
May 27, 2026

Goliath Resources Mobilizes For A Fully Funded 50,000 Meter Expansion Drill Program On Surebet Discovery, Golden Triangle, B.C.

Indeterminate GlobeNewswire
Maze Therapeutics to Participate in Two Upcoming Investor Conferences
May 27, 2026

Maze Therapeutics to Participate in Two Upcoming Investor Conferences

Indeterminate GlobeNewswire
Invivyd to Participate in Upcoming Investor Events
May 27, 2026

Invivyd to Participate in Upcoming Investor Events

Indeterminate GlobeNewswire
MitoRx Therapeutics to present new preclinical data on MTRX31, its novel mitochondrial-targeted small molecule at the American Diabetes Association’s 2026 Scientific Sessions
May 27, 2026

MitoRx Therapeutics to present new preclinical data on MTRX31, its novel mitochondrial-targeted small molecule at the American Diabetes Association’s 2026 Scientific Sessions

Indeterminate GlobeNewswire
Major Drilling to Release Results for its Fourth Fiscal Quarter and Fiscal 2026 on Wednesday, June 10, 2026
May 27, 2026

Major Drilling to Release Results for its Fourth Fiscal Quarter and Fiscal 2026 on Wednesday, June 10, 2026

Indeterminate GlobeNewswire
BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting
May 27, 2026

BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting

Indeterminate GlobeNewswire
Beamr Issues Q1-2026 CEO Letter to Shareholders: Advancing Towards Strategic Account Agreements
May 27, 2026

Beamr Issues Q1-2026 CEO Letter to Shareholders: Advancing Towards Strategic Account Agreements

Indeterminate GlobeNewswire
Erdene Releases 2026 Shareholder Letter and Provides Investor Update Webcast
May 27, 2026

Erdene Releases 2026 Shareholder Letter and Provides Investor Update Webcast

Indeterminate GlobeNewswire
MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 27, 2026

MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East News Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.